Armstrong Advisory Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.78K Buy
+12
New +$2.96K ﹤0.01% 879

Other funds holding JAZZ

Armstrong Advisory Group's JAZZ Position: Q3 2026 in Review

Armstrong Advisory Group opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 12 shares worth $2.78K. The stake represents ﹤0.01% of the portfolio and ranks #879 among its holdings.

670 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Armstrong Advisory Group held 12 shares of Jazz Pharmaceuticals worth $2.78K as of Q3 2026.
  • Jazz Pharmaceuticals was a new Armstrong Advisory Group position in Q3 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #879 holding.
  • 670 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.